Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Minim Invasive Gynecol. 2014 Sep 19;22(2):185–192. doi: 10.1016/j.jmig.2014.09.005

Table 1.

Clinical and demographic characteristics of patients (N=808)

Potential Risk Factors Number of Patients Percentage
Race
    Caucasian 503 62.3
    African American 174 21.5
    Hispanic 97 12.0
    Asian 16 2.0
    Other 18 2.2
Age
    Younger than 40 years 194 24.0
    40-50 years 451 55.8
    Older than 50 years 163 20.2
Perimenopausal or postmenopausal status 75 9.3
History of infertility 18 2.2
History of polycystic ovarian syndrome 13 1.6
History of diabetes 26 3.2
History of hypertension 158 19.6
History of cancer 28 3.5
History of tamoxifen use 5 0.6
History of hormone replacement therapy 34 4.2
Oral contraceptive use (ever users) 248 30.7
History of smoking 92 11.4
Potential Risk Factors Number of Patients Percentage
Family history of ovarian, breast, endometrial, or colorectal cancer 94 11.8
Preoperative Pap test results (within 1 year) 713 88.2
    Normal 698 97.9
    Abnormal1 15 2.1
Preoperative or intraoperative endocervical curettage 30 3.7
Preoperative ultrasonography 458 56.7
1

Abnormal pap tests included atypical squamous cells of undetermined significance with either negative HPV or colposcopic evaluation (n=13), cervical intraepithelial neoplasia (CIN) 2 on pap test and colposcopy (n=1), and endometrial cells on pap test (n=1).